Caricamento...
Antiangiogenic therapies in urogenital malignancies: Fiction or fact?
The use of antiangiogenic agents in cancer therapy has become an attractive target in oncological research. However, concerning the uro-oncological field, current guidelines only recommend the use of antiangiogenic agents in metastatic renal cell cancer. Yet in recent years, several approaches for s...
Salvato in:
| Pubblicato in: | Memo |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Vienna
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5725505/ https://ncbi.nlm.nih.gov/pubmed/29250197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-017-0375-8 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|